Connection
David Simpson to Blood-Brain Barrier
This is a "connection" page, showing publications David Simpson has written about Blood-Brain Barrier.
|
|
Connection Strength |
|
 |
|
 |
|
0.163 |
|
|
|
-
Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA. Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis. 2014 Apr; 58(7):1015-22.
Score: 0.107
-
Yang Y, Simpson D, Hu B, Liu J, Xiong L. Cerebrovascular Regulation in Neurological Disorders. Biomed Res Int. 2018; 2018:8140545.
Score: 0.037
-
Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 Jan 02; 23(1):83-7.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|